COLORS-Validate Study of Decision-Support Software for Surgical Sequencing in Colorectal Liver Metastases

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences

About this trial

This study evaluates a surgical decision-support software designed to assist physicians in selecting the optimal surgical sequence for patients with colorectal cancer liver metastases.

In this multicenter prospective simulation study, participating surgeons from multiple centers will review standardized clinical case scenarios. For each case, physicians will first make a surgical sequencing decision based on their own clinical judgment. They will then review the recommendation provided by the decision-support software and make a second decision if they choose to revise their initial plan.

The study will assess whether the software influences clinical decision-making, including changes in surgical strategy, decision confidence, decision time, and agreement with software recommendations. Physician user experience will also be evaluated using standardized questionnaires, including system usability and cognitive workload scales.

The goal of this study is to determine the clinical utility and usability of the decision-support software in improving surgical decision-making consistency and supporting clinical reasoning in colorectal liver metastases cases.

Eligibility criteria

Qualifiers

Licensed physicians specializing in hepatobiliary surgery or colorectal surgery

At least 1 year of clinical experience after graduation

Willing to participate in the simulation-based decision-making study

Practicing at one of the participating tertiary academic hospitals

Disqualifiers

Not actively involved in clinical surgical decision-making

Unable to complete all required simulation sessions

Prior involvement in the development of the decision-support software

Trial design

Treatments tested in this trial

  • Unaided Clinical Decision-Making
  • Software-Assisted Clinical Decision-Making

Treatment groups

12 Participants
are divided into 2 treatment groups

Locations

This trial has no locations